Dilution profile // every instrument, one screen, from SEC filings

BLUE BIOFUELS, INC. (BIOF)

CIK 1549145 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed sub-ratings (cash need)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
LOWno live registration found
= is there a registration (S-1/S-3 family) on file without a later withdrawal
Overhead supply
LOWwarrants = 7% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW+7% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
HIGH~0.3 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2021-05-122026-08-09

Latest: 324.2M shares as of Aug 9, 2026 (10-Q).

⊙
EVIDENCE — filed/published fact
SourceSEC XBRL, cover-page share count
Fielddei:EntityCommonStockSharesOutstanding
As of2026-08-09
HowThe newest cover-page count as filed, whatever its age. The float checker applies a 200-day freshness rule and sets this beside the balance-sheet count.
Open the source document →

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 22.7M underlying shares, as reported Jun 30, 2024 (10-Q).

Reported exercise price: $0.15 (aggregate figure as tagged; individual tranches vary).

Rough fully diluted estimate: 346.8M = 324.2M O/S + 22.7M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 10, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding324.2MAug 9, 2026
+ Warrants (aggregate, as tagged) (if exercised)22.7MJun 30, 2024
Fully diluted estimate346.8M+7.0% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Last 12 months: 0 executed · 0 registered.

WITHDRAWNMay 2, 2022Registration withdrawnRW →
REGISTEREDFeb 7, 2022S-1 registration — capacity to sell shares, not a sale yetS-1 →
EXECUTEDMar 21, 2016Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDFeb 4, 2014Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDNov 5, 2013Unregistered share sale disclosed (8-K item 3.02)8-K →
EFFECTIVEOct 19, 2012SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDOct 4, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDSep 19, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDAug 31, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDJul 24, 2012S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDMay 23, 2012S-1 registration — capacity to sell shares, not a sale yetS-1 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full BIOF workspace